Urinary TIMP-2 × IGFBP7 and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients

摘要

Flowchart of study design. The chart shows patient inclusion and exclusion in the study analysis. ICU: intensive care unit; [TIMP-2] × [IGFBP7]: urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor binding protein 7 product